Preventing the forgotten ureteral stent: implementation of a web-based stent registry with automatic recall application

MF Lynch, KR Ghani, I Frost, KM Anson - Urology, 2007 - Elsevier
OBJECTIVES: To describe and analyze a unique computerized system that tracks ureteral
stents and automatically sends a notice by e-mail to clinical staff if a stent becomes overdue …

Further evaluations of nivolumab (nivo) versus investigator's choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and …

…, RI Haddad, N Kiyota, M Tahara, M Monga, MJ Lynch… - 2016 - ascopubs.org
6009 Background: Patients (pts) with R/M SCCHN have poor prognosis, and median OS for
pts with platinum-refractory disease is ≤6 mo. We investigated if nivo, a fully human IgG4 …

Percutaneous nephrostomy and ureteric stent insertion for acute renal deobstruction Consensus based guidance

MF Lynch, KM Anson, U Patel - British Journal of Medical …, 2008 - journals.sagepub.com
Objective: Ureteric obstruction can be relieved by either percutaneous nephrostomy (PCN)
or retrograde ureteric stenting (RUS). Both are associated with variable technical success, …

[HTML][HTML] VKORC1 sequence variants associated with resistance to anticoagulant rodenticides in Irish populations of Rattus norvegicus and Mus musculus domesticus

J Mooney, MR Lynch, CV Prescott, T Clegg… - Scientific reports, 2018 - nature.com
While resistance to anticoagulant rodenticides is known to occur in many European
populations of Norway rat and house mouse, to-date no data is available on the occurrence in …

Large amplitude instability in finite difference approximations to the Klein–Gordon equation

MAM Lynch - Applied Numerical Mathematics, 1999 - Elsevier
In a paper by Jiminez and Vazquez (1990), four finite difference schemes for approximating
the nonlinear Klein–Gordon equation were discussed. They observed undesirable …

[PDF][PDF] Current opinion amongst radiologists and urologists in the UK on percutaneous nephrostomy and ureteric stent insertion for acute renal unobstruction: Results …

MF Lynch, KM Anson, U Patel - BJU international, 2006 - academia.edu
Percutaneous nephrostomy (PCN) and ureteric stenting have been in clinical use for the last
three or more decades, but there are still no approved guidelines for the recommended use …

Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

…, N Yan, AD Cox, X Bustelo, SM Graham, MJ Lynch… - Oncogene, 1995 - europepmc.org
Recent results from several laboratories including ours strongly suggest that farnesyltransferase
(FT) inhibitors belonging to distinct chemical classes block growth of oncogenic Ras …

Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene

T Saeki, A Cristiano, MJ Lynch, M Brattain… - Molecular …, 1991 - academic.oup.com
Expression of transforming growth factor α (TGFα) mRNA and protein can be stimulated by
estrogens such as 17β-estradiol (E 2 ) in estrogen-responsive rodent and human breast …

Ras farnesylation as a target for novel antitumor agents: potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase

…, N Yan, D Patel, R Schmidt, MJ Lynch… - Drug development …, 1995 - Wiley Online Library
Protein prenylation is increasingly recognized as an important mechanism by which
functional association of proteins to membranes is mediated. Ras proteins, regulators of cell …

Nivolumab (Nivo) vs investigator's choice (IC) for platinum-refractory (PR) recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN; …

…, RI Haddad, T Rordorf, N Kiyota, M Tahara, MJ Lynch… - 2017 - ascopubs.org
6019 Background: In CheckMate 141, a randomized, phase 3 trial, nivo demonstrated
superior overall survival (OS) and better tolerability in patients (pts) with PR R/M SCCHN …